The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
500 jobs Number of planned job losses
Announcement Date
6 December 2004
Employment effect (start)
Foreseen end date
Description
As a result of the merger between Pharmacia and Pfizer (in 2003), the American group Pfizer announced on Monday 6 December 2004 a second round of restructuring measures. Both production sites of Angers and Val de Reuil will be closed, causing the loss of 500 jobs. Further European measures are expected to come. In 2003, the R&D unit in Fresnes had also been closed provoking the loss of 285 jobs.
Sources
8 December 2004: Les Echos
Citation
Eurofound (2004), Pfizer - Pharmacia, Merger/Acquisition in France, factsheet number 60877, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/60877.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
